Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-8962 (Corifollitropin Alfa) + hCG in Adolescent Males with Hypogonadotropic Hypogonadism
NCT03019575Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2017
- Primary completion
- May 2020
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 6
01
Overview
A Phase 3 trial of corifollitropin alfa in hypogonadotropic hypogonadism (HH), sponsored by Organon & Co.. Started Feb 2017; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT03019575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03019575.